Signaling by IL-31 and functional consequences

被引:173
作者
Cornelissen, Christian [1 ]
Luescher-Firzlaff, Juliane [1 ]
Baron, Jens Malte [2 ]
Luescher, Bernhard [1 ]
机构
[1] Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, D-52074 Aachen, Germany
[2] Rhein Westfal TH Aachen, Sch Med, Dept Dermatol & Allergol, D-52074 Aachen, Germany
关键词
Allergy; Atopic dermatitis; Cytokine; Differentiation; Immune response; Innate immunity; Keratinocyte; Pruritus; Skin; FC-EPSILON-RI; ONCOSTATIN-M; NC/NGA MICE; CYTOKINE RECEPTOR; GROWTH-FACTOR; T-CELLS; EPITHELIAL-CELLS; EPIDERMAL-KERATINOCYTES; INTERLEUKIN-31; RECEPTOR; NEUTROPHIL RECRUITMENT;
D O I
10.1016/j.ejcb.2011.07.006
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Cytokines are key to control cellular communication. Interleukin-31 (IL-31) was recently discovered as a new member of the IL-6 family of cytokines. IL-31 signals through a heterodimeric receptor composed of OSMR and IL-31RA, a complex that stimulates the JAK-STAT, the RAS/ERK and the PI3K/AKT signal transduction pathways. The available data suggests that IL-31 is important for both innate and adaptive immunity in tissues that are in close contact with the environment, i.e. the skin, the airways and the lung, and the lining of the intestine. Enhanced expression of IL-31 is associated with a number of diseases, including pruritic diseases such as atopic dermatitis, but also in allergy and inflammatory bowel disease. In these tissues IL-31 coordinates the interaction of different immune cells, including T-cells, mast cells, and eosinophils, with epithelial cells. In this review we have summarized the available data on IL-31 and its receptor, their expression pattern and how they are regulated. We describe the current state of knowledge of the involvement of IL-31 in diseases, both in humans and in mouse models. From these studies it is becoming clear that IL-31 plays an important role in the proper functioning of the skin and of airway and intestinal epithelia. The findings available suggest that IL-31 might be an interesting target for directed drug therapy. (C) 2011 Elsevier GmbH. All rights reserved.
引用
收藏
页码:552 / 566
页数:15
相关论文
共 114 条
[1]
Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway [J].
Amishima, M ;
Munakata, M ;
Nasuhara, Y ;
Sato, A ;
Takahashi, T ;
Homma, Y ;
Kawakami, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) :1907-1912
[2]
Mucosal cytokine network in inflammatory bowel disease [J].
Andoh, Akira ;
Yagi, Yuhki ;
Shioya, Makoto ;
Nishida, Atsushi ;
Tsujikawa, Tomoyuki ;
Fujiyama, Yoshihide .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (33) :5154-5161
[3]
Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis [J].
Arai, I ;
Takano, N ;
Hashimoto, Y ;
Futaki, N ;
Sugimoto, M ;
Takahashi, N ;
Inoue, T ;
Nakaike, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 505 (1-3) :229-235
[4]
Complete overlap of interleukin-31 receptor A and oncostatin M receptor β in the adult dorsal root ganglia with distinct developmental expression patterns [J].
Bando, T. ;
Morikawa, Y. ;
Komori, T. ;
Senba, E. .
NEUROSCIENCE, 2006, 142 (04) :1263-1271
[5]
HEMATOPOIETIC RECEPTORS AND HELICAL CYTOKINES [J].
BAZAN, JF .
IMMUNOLOGY TODAY, 1990, 11 (10) :350-354
[7]
PROTEIN-TYROSINE-PHOSPHATASE SHPTP2 COUPLES PLATELET-DERIVED GROWTH-FACTOR RECEPTOR-BETA TO RAS [J].
BENNETT, AM ;
TANG, TL ;
SUGIMOTO, S ;
WALSH, CT ;
NEEL, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7335-7339
[8]
Atopic Dermatitis [J].
Bieber, Thomas .
ANNALS OF DERMATOLOGY, 2010, 22 (02) :125-137
[9]
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis [J].
Bilsborough, J ;
Leung, DYM ;
Maurer, M ;
Howell, M ;
Boguniewcz, M ;
Yao, L ;
Storey, H ;
LeCiel, C ;
Harder, B ;
Gross, JA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) :418-425
[10]
IL-31 Receptor (IL-31RA) Knockout Mice Exhibit Elevated Responsiveness to Oncostatin M [J].
Bilsborough, Janine ;
Mudri, Sherri ;
Chadwick, Eric ;
Harder, Brandon ;
Dillon, Stacey R. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (10) :6023-6030